Stacking GLP-1s: What Bodybuilders Are Actually Doing

The bodybuilding and fitness community has adopted GLP-1 medications with characteristic enthusiasm—and characteristic disregard for official protocols. From Reddit's r/steroids to private Discord servers to hushed conversations in gym locker rooms, a parallel knowledge base has emerged around "stacking" GLP-1s with other compounds. Some of these practices are backed by emerging science. Others are pure speculation. Here's an honest assessment of what's actually happening.

The Baseline: Why Fitness Enthusiasts Use GLP-1s

Before examining stacking practices, understand why GLP-1s have penetrated fitness culture:

Cutting tool. For bodybuilders preparing for competition or physique-conscious men wanting to get lean, GLP-1s offer a powerful appetite suppression that makes aggressive caloric deficits tolerable. The "food noise" reduction is particularly valued during cuts, when willpower typically depletes.

Recomposition potential. While GLP-1s alone tend to cause some muscle loss, when combined with adequate protein and resistance training, the ratio of fat loss to muscle loss improves significantly. For enhanced athletes (using anabolics), this concern is further mitigated.

Health optimization. Even fitness-focused men carry visceral fat and metabolic dysfunction. GLP-1s offer cardiovascular protection, improved insulin sensitivity, and reduced inflammation—benefits that matter regardless of aesthetic goals.

Low-dose "optimization." A growing contingent of already-lean men use microdoses (0.25-0.5mg semaglutide) not for weight loss but for purported metabolic optimization benefits—a practice with minimal evidence but significant popularity.

Stack #1: GLP-1 + Testosterone/TRT

The rationale: Testosterone provides anabolic signaling that helps preserve muscle during the catabolic environment of caloric restriction. TRT users adding GLP-1s report better body composition changes than with either agent alone.

The evidence: The ENDO 2025 data showed tirzepatide actually increased LH and FSH in obese men—suggesting it restores rather than suppresses the natural hormonal axis. For men already on TRT (who've externally suppressed their axis), GLP-1 addition shouldn't negatively interact. No significant drug-drug interactions have been identified.

The practice: Men on TRT (typically 100-200mg testosterone weekly) add GLP-1s at standard titration schedules. Protein intake is emphasized (1.5-2g/kg) to maximize the anabolic environment for muscle preservation during fat loss.

Risk assessment: Relatively low risk when both compounds are medically supervised. The main concern is ensuring adequate nutrition when appetite is heavily suppressed—which becomes more important when trying to preserve muscle.

Stack #2: GLP-1 + Higher-Dose Anabolics

The rationale: Competitive bodybuilders and enhanced recreational users view GLP-1s as a cutting tool that allows faster, more aggressive fat loss while supraphysiological testosterone (and other anabolics) protect against muscle catabolism.

The evidence: Essentially none for this specific combination. The bodybuilding community is running an uncontrolled experiment on itself.

The practice: Enhanced users report using GLP-1s during "cutting" phases alongside compounds like testosterone, trenbolone, or other anabolics. Doses vary widely. Some use low-dose GLP-1s year-round; others use full doses only during pre-competition cuts.

Risk assessment: Elevated. Both GLP-1s and anabolic steroids carry independent cardiovascular risks. Combining them in the absence of clinical guidance is experimental. The suppressed appetite from GLP-1s combined with the increased caloric needs of enhanced training creates potential for significant undernutrition.

Stack #3: GLP-1 + Growth Hormone (GH)

The rationale: Growth hormone has lipolytic (fat-burning) effects and muscle-sparing properties. Combining with GLP-1 appetite suppression theoretically accelerates fat loss while protecting lean tissue.

The evidence: No clinical trials of this combination exist. Theoretically, GH's effects on insulin sensitivity (it can cause insulin resistance) might interact with GLP-1's glucose-lowering effects in unpredictable ways.

The practice: Users report adding GH (typically 2-4 IU daily) to GLP-1 protocols. Some alternate timing (GH in the morning, GLP-1 injection day independent) to minimize potential interactions.

Risk assessment: Moderate to elevated. GH has its own side effect profile (joint pain, water retention, potential diabetes acceleration). Combined with GLP-1s, metabolic effects are difficult to predict. Blood glucose monitoring is essential.

Stack #4: GLP-1 + Peptides (BPC-157, TB-500)

The rationale: Healing peptides like BPC-157 and TB-500 are popular in fitness communities for injury recovery and general tissue health. Some users add them to GLP-1 protocols believing they might counteract GI side effects or support tissue health during rapid weight loss.

The evidence: Near zero. BPC-157 and TB-500 have limited human data generally, and no data in combination with GLP-1s specifically.

The practice: Users inject BPC-157 (250-500mcg daily) alongside GLP-1s, often claiming reduced GI side effects. Whether this reflects placebo, genuine interaction, or coincidental timing is impossible to determine.

Risk assessment: Unknown. These peptides are largely unregulated and often of questionable purity. The theoretical mechanism for GI benefit is speculative.

The Emerging Clinical Stack: GLP-1 + Bimagrumab

The rationale: This is the one combination being studied clinically. Bimagrumab blocks activin type II receptors that inhibit muscle growth. Combined with GLP-1s, the hypothesis is you get the fat loss without the muscle loss.

The evidence: The BELIEVE trial showed promising results: 22.1% weight loss with the combination versus 15.7% with semaglutide alone, but crucially, 92.8% of weight loss came from fat mass (versus ~70% typically). Lean mass loss was reduced by 67% compared to GLP-1 alone.

The practice: Not yet available. Eli Lilly acquired bimagrumab for up to $1.9 billion, and tirzepatide + bimagrumab trials are underway. However, Lilly cancelled one Phase 2 trial in September 2025 for "strategic business reasons," creating timeline uncertainty.

Risk assessment: TBD. This will be the first rigorously studied "muscle-preserving" GLP-1 stack. If approved, it would represent a significant advancement over current protocols.

What Actually Works for Muscle Preservation (Without Exotic Stacks)

Before reaching for additional compounds, the evidence-based muscle preservation protocol is straightforward:

Protein at 1.2-1.5g per kilogram of body weight daily. The 2025 Medscape study found that adults following this protocol achieved approximately 13% body weight loss with only 3% muscle mass loss—dramatically better than typical GLP-1 outcomes.

Protein distribution across meals. Breakfast is critical after overnight fasting. Evening protein supports overnight recovery. Multiple protein "pulses" throughout the day optimize muscle protein synthesis.

Resistance training 2-3 times weekly. Progressive overload signals muscle to be preserved even in caloric deficit. This is non-negotiable for anyone prioritizing body composition.

Adequate caloric intake. Aggressive deficits accelerate muscle loss. A moderate deficit (500-750 calories) produces better body composition outcomes than extreme restriction, even if weight loss is slower.

These fundamentals work. Most men who "need" to stack additional compounds simply aren't optimizing these basics.

Harm Reduction for Those Who Will Stack Anyway

Some readers will combine compounds regardless of warnings. For those individuals, harm reduction principles apply:

One variable at a time. Don't start multiple new compounds simultaneously. You won't know what's causing effects—good or bad. Add one compound, stabilize, assess, then consider additions.

Regular bloodwork. At minimum: complete metabolic panel, lipids, fasting glucose/HbA1c, testosterone (if relevant), liver enzymes. Quarterly during active experimentation.

Source quality matters. Peptides and research chemicals from unregulated sources vary wildly in purity and dosing accuracy. What you think you're taking may not be what you're actually taking.

Document everything. Doses, timing, subjective effects, objective measurements. Pattern recognition requires data.

Know when to stop. Persistent side effects, concerning bloodwork, or functional impairment are signals to pause and reassess, not push through.

The Bottom Line

The fitness community has adopted GLP-1s and begun stacking them with other compounds in ways that far outpace clinical evidence. Some combinations (GLP-1 + TRT) have reasonable theoretical support and manageable risk profiles. Others (multiple unregulated peptides) are essentially experiments with unknown outcomes.

The most effective "stack" for most men remains boring: GLP-1 medication + adequate protein + resistance training + moderate caloric deficit + patience. This combination, applied consistently, produces excellent body composition outcomes without the complexity and risk of additional compounds.

For those who will stack anyway, approaching it with harm reduction principles, regular monitoring, and honest assessment of risk-benefit is essential. The goal is optimizing long-term health, not winning a short-term experiment at the cost of your future wellbeing.

Related Articles